Re: The 3 inflection points: SSRA, Top-Line, Full Data
in response to
by
posted on
Sep 10, 2018 09:26AM
Koo,
You clearly didn't thoroughly read those top line data examples. The Jardiance/empagliflozin EMPA-REG Outcomes trial top line release did not state the 14% RRR. The full data release, including the 14% RRR statement came at the September 2015 EASD meeting, which came after the August 2015 top line data statement.
BearDownAZ